BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 29925683)

  • 1. Monitoring liver damage using hepatocyte-specific methylation markers in cell-free circulating DNA.
    Lehmann-Werman R; Magenheim J; Moss J; Neiman D; Abraham O; Piyanzin S; Zemmour H; Fox I; Dor T; Grompe M; Landesberg G; Loza BL; Shaked A; Olthoff K; Glaser B; Shemer R; Dor Y
    JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digital Droplet PCR for Monitoring Tissue-Specific Cell Death Using DNA Methylation Patterns of Circulating Cell-Free DNA.
    Shemer R; Magenheim J; Dor Y
    Curr Protoc Mol Biol; 2019 Jun; 127(1):e90. PubMed ID: 31237424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte-derived microRNAs as serum biomarkers of hepatic injury and rejection after liver transplantation.
    Farid WR; Pan Q; van der Meer AJ; de Ruiter PE; Ramakrishnaiah V; de Jonge J; Kwekkeboom J; Janssen HL; Metselaar HJ; Tilanus HW; Kazemier G; van der Laan LJ
    Liver Transpl; 2012 Mar; 18(3):290-7. PubMed ID: 21932376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low Levels of Hepatocyte-Specific Methylation in Cell-Free DNA Are a Strong Negative Predictor for Acute T Cell-Mediated Rejection Requiring Treatment Following Liver Transplantation.
    Cox DRA; Low N; Goh SK; Lee E; Vago A; Jackett L; Lokan J; Braat S; Jones R; Testro A; Dobrovic A; Muralidharan V
    Liver Transpl; 2022 Jun; 28(6):1024-1038. PubMed ID: 34919754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive detection of human cardiomyocyte death using methylation patterns of circulating DNA.
    Zemmour H; Planer D; Magenheim J; Moss J; Neiman D; Gilon D; Korach A; Glaser B; Shemer R; Landesberg G; Dor Y
    Nat Commun; 2018 Apr; 9(1):1443. PubMed ID: 29691397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive DNA methylation analysis of tissue of origin of plasma cell-free DNA by methylated CpG tandem amplification and sequencing (MCTA-Seq).
    Liu X; Ren J; Luo N; Guo H; Zheng Y; Li J; Tang F; Wen L; Peng J
    Clin Epigenetics; 2019 Jun; 11(1):93. PubMed ID: 31234922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of fragment size distribution of cell-free DNA: A potential non-invasive marker to monitor graft damage in living-related liver transplantation for inborn errors of metabolism.
    Ng HI; Zhu X; Xuan L; Long Y; Mao Y; Shi Y; Sun L; Liang B; Scaglia F; Choy KW; Zhu Z
    Mol Genet Metab; 2019 May; 127(1):45-50. PubMed ID: 31027872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of 12 different kits for bisulfite conversion of circulating cell-free DNA.
    Worm Ørntoft MB; Jensen SØ; Hansen TB; Bramsen JB; Andersen CL
    Epigenetics; 2017 Aug; 12(8):626-636. PubMed ID: 28557629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplexing DNA methylation markers to detect circulating cell-free DNA derived from human pancreatic β cells.
    Neiman D; Gillis D; Piyanzin S; Cohen D; Fridlich O; Moss J; Zick A; Oron T; Sundberg F; Forsander G; Skog O; Korsgren O; Levy-Khademi F; Arbel D; Hashavia S; Shapiro AMJ; Speake C; Greenbaum C; Hosford J; Posgai A; Atkinson MA; Glaser B; Schatz DA; Shemer R; Dor Y
    JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32573495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of tissue-specific cell death using methylation patterns of circulating DNA.
    Lehmann-Werman R; Neiman D; Zemmour H; Moss J; Magenheim J; Vaknin-Dembinsky A; Rubertsson S; Nellgård B; Blennow K; Zetterberg H; Spalding K; Haller MJ; Wasserfall CH; Schatz DA; Greenbaum CJ; Dorrell C; Grompe M; Zick A; Hubert A; Maoz M; Fendrich V; Bartsch DK; Golan T; Ben Sasson SA; Zamir G; Razin A; Cedar H; Shapiro AM; Glaser B; Shemer R; Dor Y
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):E1826-34. PubMed ID: 26976580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics, properties, and potential applications of circulating cell-free dna in clinical diagnostics: a focus on transplantation.
    Sherwood K; Weimer ET
    J Immunol Methods; 2018 Dec; 463():27-38. PubMed ID: 30267663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graft-derived cell-free DNA, a noninvasive early rejection and graft damage marker in liver transplantation: A prospective, observational, multicenter cohort study.
    Schütz E; Fischer A; Beck J; Harden M; Koch M; Wuensch T; Stockmann M; Nashan B; Kollmar O; Matthaei J; Kanzow P; Walson PD; Brockmöller J; Oellerich M
    PLoS Med; 2017 Apr; 14(4):e1002286. PubMed ID: 28441386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-free DNA donor fraction analysis in pediatric and adult heart transplant patients by multiplexed allele-specific quantitative PCR: Validation of a rapid and highly sensitive clinical test for stratification of rejection probability.
    North PE; Ziegler E; Mahnke DK; Stamm KD; Thomm A; Daft P; Goetsch M; Liang HL; Baker MA; Vepraskas A; Rosenau C; Dasgupta M; Simpson P; Mitchell ME; Tomita-Mitchell A
    PLoS One; 2020; 15(1):e0227385. PubMed ID: 31929557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative Methylation-Specific PCR: A Simple Method for Studying Epigenetic Modifications of Cell-Free DNA.
    Sigalotti L; Covre A; Colizzi F; Fratta E
    Methods Mol Biol; 2019; 1909():137-162. PubMed ID: 30580429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid biopsy reveals collateral tissue damage in cancer.
    Lubotzky A; Zemmour H; Neiman D; Gotkine M; Loyfer N; Piyanzin S; Ochana BL; Lehmann-Werman R; Cohen D; Moss J; Magenheim J; Loftus MF; Brais L; Ng K; Mostoslavsky R; Wolpin BM; Zick A; Maoz M; Grinshpun A; Kustanovich A; Makranz C; Cohen JE; Peretz T; Hubert A; Temper M; Salah A; Avniel-Polak S; Grozinsky-Glasberg S; Spalding KL; Rokach A; Kaplan T; Glaser B; Shemer R; Dor Y
    JCI Insight; 2022 Jan; 7(2):. PubMed ID: 35076021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
    Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
    Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Universal lung epithelium DNA methylation markers for detection of lung damage in liquid biopsies.
    Magenheim J; Rokach A; Peretz A; Loyfer N; Cann G; Amini H; Moradi P; Nagaraju S; Sameer W; Cohen A; Fogel O; Kuint R; Abutbul A; Abu Rmeileh A; Karameh M; Cohen Goichman P; Wald O; Korach A; Neiman D; Fox-Fisher I; Moss J; Cohen D; Piyanzin S; Ben Ami R; Quteineh A; Golomb E; Shemer R; Glaser B; Kaplan T; Fridlender ZG; Dor Y
    Eur Respir J; 2022 Nov; 60(5):. PubMed ID: 35450968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated Plasma Levels of Cell-Free DNA During Liver Transplantation Are Associated With Activation of Coagulation.
    von Meijenfeldt FA; Burlage LC; Bos S; Adelmeijer J; Porte RJ; Lisman T
    Liver Transpl; 2018 Dec; 24(12):1716-1725. PubMed ID: 30168653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Liver disorders in adults: ALT and AST].
    Goorden SM; Buffart TE; Bakker A; Buijs MM
    Ned Tijdschr Geneeskd; 2013; 157(43):A6443. PubMed ID: 24152362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of oxygen intake and liver enzyme on the dynamics of damaged hepatocytes: Implications to ischaemic liver injury via a mathematical model.
    Ghosh A; Onsager C; Mason A; Arriola L; Lee W; Mubayi A
    PLoS One; 2021; 16(4):e0230833. PubMed ID: 33886563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.